Skip to main content
Top
Published in: Rheumatology International 11/2017

01-11-2017 | Genes and Disease

Association of TLR4 gene polymorphisms with childhood Henoch–Schönlein purpura in a Chinese population

Authors: Hui Xu, Guizhen Jiang, Hongqiang Shen, Wei Li, Jianhua Mao, Yanxiang Pan

Published in: Rheumatology International | Issue 11/2017

Login to get access

Abstract

Recent studies demonstrated that aberrant activation of Toll-like receptor (TLR) 4 was involved in the pathogenesis of Henoch–Schönlein purpura (HSP). In this study, we evaluated the association between TLR4 gene polymorphisms and the risk of childhood HSP in a Chinese population. A total of 175 HSP patients and 186 controls were recruited in this case–control study. Three single-nucleotide polymorphisms of the TLR4 gene (rs1927914, rs10759932 and rs1927907) were genotyped using the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and Sequenom MassARRAY system. Our results revealed that a significantly reduced risk for HSP was associated with the G allele (OR = 0.71; p = 0.023) and G/G genotype (OR = 0.49; p = 0.021) of rs1927914. We also showed that rs1927914 variant decreased the risk of HSP in recessive inheritance model (OR = 0.55; p = 0.035, G/G vs A/A + A/G). In addition, we observed that a significantly decreased frequency of the haplotype GTC (rs1927914-rs10759932-rs1927907) in HSP patients compared with controls (OR = 0.56; p = 0.028). Our data suggested that TLR 4 rs1927914 polymorphism was associated with the decreased susceptibility to HSP in the Chinese children.
Literature
2.
go back to reference Kraft DM, Mckee D, Scott C (1998) Henoch–Schönlein purpura: a review. Am Fam Physician 58(2):405–408PubMed Kraft DM, Mckee D, Scott C (1998) Henoch–Schönlein purpura: a review. Am Fam Physician 58(2):405–408PubMed
3.
go back to reference Trnka P (2013) Henoch–Schönlein purpura in children. J Paediatr Child Health 49:995–1003CrossRefPubMed Trnka P (2013) Henoch–Schönlein purpura in children. J Paediatr Child Health 49:995–1003CrossRefPubMed
4.
go back to reference Eleftheriou D, Brogan PA (2009) Vasculitis in children. Best Pract Res Clin Rheumatol 23:309–323CrossRefPubMed Eleftheriou D, Brogan PA (2009) Vasculitis in children. Best Pract Res Clin Rheumatol 23:309–323CrossRefPubMed
5.
go back to reference Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675–680CrossRefPubMed Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675–680CrossRefPubMed
6.
go back to reference Leon CG, Tory R, Jia J et al (2008) Discovery and development of Toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm Res 25:1751–1761CrossRefPubMedPubMedCentral Leon CG, Tory R, Jia J et al (2008) Discovery and development of Toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm Res 25:1751–1761CrossRefPubMedPubMedCentral
7.
go back to reference Liaunardy-Jopeace A, Gay NJ (2014) Molecular and cellular regulation of Toll-like receptor-4 activity induced by lipopolysaccharide ligands. Front Immunol 5:473CrossRefPubMedPubMedCentral Liaunardy-Jopeace A, Gay NJ (2014) Molecular and cellular regulation of Toll-like receptor-4 activity induced by lipopolysaccharide ligands. Front Immunol 5:473CrossRefPubMedPubMedCentral
8.
go back to reference Donadio ME, Loiacono E, Peruzzi L et al (2014) Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch-Schönlein purpura and primary IgA nephropathy. Pediatr Nephrol 29:1545–1551CrossRefPubMed Donadio ME, Loiacono E, Peruzzi L et al (2014) Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch-Schönlein purpura and primary IgA nephropathy. Pediatr Nephrol 29:1545–1551CrossRefPubMed
9.
go back to reference Chang H, Yu DS, Liu XQ et al (2014) Clinical significance of TLR3 and TLR4 in peripheral blood mononuclear cells from children with Henoch–Schönlein purpura nephritis. Exp Ther Med 7:1703–1707CrossRefPubMedPubMedCentral Chang H, Yu DS, Liu XQ et al (2014) Clinical significance of TLR3 and TLR4 in peripheral blood mononuclear cells from children with Henoch–Schönlein purpura nephritis. Exp Ther Med 7:1703–1707CrossRefPubMedPubMedCentral
10.
go back to reference Chang H, Zhang QY, Lin Y et al (2015) Correlation of TLR2 and TLR4 expressions in peripheral blood mononuclear cells to Th1- and Th2-type immune responses in children with Henoch–Schönlein purpura. Int J Clin Exp Med 8:13532–13539PubMedPubMedCentral Chang H, Zhang QY, Lin Y et al (2015) Correlation of TLR2 and TLR4 expressions in peripheral blood mononuclear cells to Th1- and Th2-type immune responses in children with Henoch–Schönlein purpura. Int J Clin Exp Med 8:13532–13539PubMedPubMedCentral
11.
go back to reference Noreen M, Shah MA, Mall SM et al (2012) TLR4 polymorphisms and disease susceptibility. Inflamm Res 61:177–188CrossRefPubMed Noreen M, Shah MA, Mall SM et al (2012) TLR4 polymorphisms and disease susceptibility. Inflamm Res 61:177–188CrossRefPubMed
12.
go back to reference Dunstan E, Lester S, Rischmueller M et al (2014) TLR4 polymorphism is not associated with biopsy proven giant cell arteritis. Clin Exp Rheumatol 32:S26–S29PubMed Dunstan E, Lester S, Rischmueller M et al (2014) TLR4 polymorphism is not associated with biopsy proven giant cell arteritis. Clin Exp Rheumatol 32:S26–S29PubMed
13.
go back to reference Palomino-Morales R, Torres O, Vazquez-Rodriguez TR et al (2009) Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis. J Rheumatol 36:1501–1506CrossRefPubMed Palomino-Morales R, Torres O, Vazquez-Rodriguez TR et al (2009) Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis. J Rheumatol 36:1501–1506CrossRefPubMed
14.
go back to reference Ben Dhifallah I, Lachheb J, Houman H et al (2009) Toll-like-receptor gene polymorphisms in a Tunisian population with Behçet’s disease. Clin Exp Rheumatol 27:S58–S62PubMed Ben Dhifallah I, Lachheb J, Houman H et al (2009) Toll-like-receptor gene polymorphisms in a Tunisian population with Behçet’s disease. Clin Exp Rheumatol 27:S58–S62PubMed
15.
go back to reference Boiardi L, Atzeni F, Casali B et al (2009) Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet’s disease. Clin Exp Rheumatol 27:S43–S47PubMed Boiardi L, Atzeni F, Casali B et al (2009) Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet’s disease. Clin Exp Rheumatol 27:S43–S47PubMed
16.
go back to reference Horie Y, Meguro A, Ota M et al (2009) Association of TLR4 polymorphisms with Behcet’s disease in a Korean population. Rheumatology 48:638–642CrossRefPubMed Horie Y, Meguro A, Ota M et al (2009) Association of TLR4 polymorphisms with Behcet’s disease in a Korean population. Rheumatology 48:638–642CrossRefPubMed
17.
go back to reference Torres O, Palomino-Morales R, Miranda-Filloy JA et al (2010) Lack of association between toll-like receptor 4 gene polymorphism and Henoch–Schönlein purpura. Clin Exp Rheumatol 28:110PubMed Torres O, Palomino-Morales R, Miranda-Filloy JA et al (2010) Lack of association between toll-like receptor 4 gene polymorphism and Henoch–Schönlein purpura. Clin Exp Rheumatol 28:110PubMed
18.
go back to reference Soylu A, Kizildağ S, Kavukçu S et al (2010) TLR-2 Arg753Gln, TLR-4 Asp299Gly, and TLR-4 Thr399Ile polymorphisms in Henoch–Schonlein purpura with and without renal involvement. Rheumatol Int 30:667–670CrossRefPubMed Soylu A, Kizildağ S, Kavukçu S et al (2010) TLR-2 Arg753Gln, TLR-4 Asp299Gly, and TLR-4 Thr399Ile polymorphisms in Henoch–Schonlein purpura with and without renal involvement. Rheumatol Int 30:667–670CrossRefPubMed
19.
go back to reference Mills JA, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch–Schönlein purpura. Arthritis Rheum 33:1114–1121CrossRefPubMed Mills JA, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch–Schönlein purpura. Arthritis Rheum 33:1114–1121CrossRefPubMed
21.
go back to reference Barrett JC, Fry B, Maller J et al (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMed Barrett JC, Fry B, Maller J et al (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMed
22.
go back to reference Molteni M, Gemma S, Rossetti C (2016) The Role of toll-like receptor 4 in infectious and noninfectious inflammation. Mediat Inflamm 2016:6978936CrossRef Molteni M, Gemma S, Rossetti C (2016) The Role of toll-like receptor 4 in infectious and noninfectious inflammation. Mediat Inflamm 2016:6978936CrossRef
23.
go back to reference Qing YF, Zhou JG, LI M et al (2013) No evidence for involvement of the toll-like receptor (TLR) 4 gene Asp299Gly and Thr399Ile polymorphisms in susceptibility to primary gouty arthritis. Rheumatol Int 33:2937–2941CrossRefPubMed Qing YF, Zhou JG, LI M et al (2013) No evidence for involvement of the toll-like receptor (TLR) 4 gene Asp299Gly and Thr399Ile polymorphisms in susceptibility to primary gouty arthritis. Rheumatol Int 33:2937–2941CrossRefPubMed
24.
go back to reference Tahara T, Arisawa T, Shibata T et al (2007) Absence of common polymorphisms of toll like receptor 4 (TLR4): Asp299Gly, Thr399Ile in patients with gastroduodenal diseases in Japan. J Clin Biochem Nutr 40:62–65CrossRefPubMed Tahara T, Arisawa T, Shibata T et al (2007) Absence of common polymorphisms of toll like receptor 4 (TLR4): Asp299Gly, Thr399Ile in patients with gastroduodenal diseases in Japan. J Clin Biochem Nutr 40:62–65CrossRefPubMed
25.
go back to reference Yoon HJ, Choi JY, Kim CO et al (2006) Lack of toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia. J Korean Med Sci 21:979–982CrossRefPubMedPubMedCentral Yoon HJ, Choi JY, Kim CO et al (2006) Lack of toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia. J Korean Med Sci 21:979–982CrossRefPubMedPubMedCentral
26.
go back to reference Kim JS, Kim SK, Park JY et al (2016) Significant association between toll-like receptor gene polymorphisms and posttransplantation diabetes mellitus. Nephron 133:279–286CrossRefPubMed Kim JS, Kim SK, Park JY et al (2016) Significant association between toll-like receptor gene polymorphisms and posttransplantation diabetes mellitus. Nephron 133:279–286CrossRefPubMed
27.
go back to reference Jiao Y, Zhao J, Hu B et al (2016) Toll-like receptor 4 gene is associated with recurrent spontaneous miscarriage in Uygur and Han women in Xinjiang. Exp Ther Med 12:3268–3274CrossRefPubMedPubMedCentral Jiao Y, Zhao J, Hu B et al (2016) Toll-like receptor 4 gene is associated with recurrent spontaneous miscarriage in Uygur and Han women in Xinjiang. Exp Ther Med 12:3268–3274CrossRefPubMedPubMedCentral
28.
go back to reference Xu Y, Jiang Z, Huang J et al (2015) The association between toll-like receptor 4 polymorphisms and diabetic retinopathy in Chinese patients with type 2 diabetes. Br J Ophthalmol 99:1301–1305CrossRefPubMed Xu Y, Jiang Z, Huang J et al (2015) The association between toll-like receptor 4 polymorphisms and diabetic retinopathy in Chinese patients with type 2 diabetes. Br J Ophthalmol 99:1301–1305CrossRefPubMed
29.
go back to reference Zhao J, Han X, Xue L et al (2015) Association of TLR4 gene polymorphisms with sporadic Parkinson’s disease in a Han Chinese population. Neurol Sci 36:1659–1665CrossRefPubMed Zhao J, Han X, Xue L et al (2015) Association of TLR4 gene polymorphisms with sporadic Parkinson’s disease in a Han Chinese population. Neurol Sci 36:1659–1665CrossRefPubMed
30.
go back to reference Zhang Q, Qian FH, Zhou LF et al (2011) Polymorphisms in toll-like receptor 4 gene are associated with asthma severity but not susceptibility in a Chinese Han population. J Investig Allergol Clin Immunol 21:370–377PubMed Zhang Q, Qian FH, Zhou LF et al (2011) Polymorphisms in toll-like receptor 4 gene are associated with asthma severity but not susceptibility in a Chinese Han population. J Investig Allergol Clin Immunol 21:370–377PubMed
31.
go back to reference Peng D, Jiang F, Zhang R et al (2015) Association of toll-like receptor 4 gene polymorphisms with susceptibility to type 2 diabetes mellitus in the Chinese population. J Diabetes 7:485–492CrossRefPubMed Peng D, Jiang F, Zhang R et al (2015) Association of toll-like receptor 4 gene polymorphisms with susceptibility to type 2 diabetes mellitus in the Chinese population. J Diabetes 7:485–492CrossRefPubMed
32.
go back to reference Castaño-Rodríguez N, Kaakoush NO, Pardo AL et al (2014) Genetic polymorphisms in the toll-like receptor signaling pathway in Helicobacter pylori infection and related gastric cancer. Hum Immunol 75:808–815CrossRefPubMed Castaño-Rodríguez N, Kaakoush NO, Pardo AL et al (2014) Genetic polymorphisms in the toll-like receptor signaling pathway in Helicobacter pylori infection and related gastric cancer. Hum Immunol 75:808–815CrossRefPubMed
33.
go back to reference Simhan HN, MacPherson T, Caritis SN et al (2008) Maternal and fetal Toll-like receptor 4 genotype and chorionic plate inflammatory lesions. Am J Obstet Gynecol 199(400):e1–e4 Simhan HN, MacPherson T, Caritis SN et al (2008) Maternal and fetal Toll-like receptor 4 genotype and chorionic plate inflammatory lesions. Am J Obstet Gynecol 199(400):e1–e4
34.
go back to reference Huang H, Wu J, Jin G et al (2010) A 5′-flanking region polymorphism in toll-like receptor 4 is associated with gastric cancer in a Chinese population. J Biomed Res 24:100–106CrossRefPubMedPubMedCentral Huang H, Wu J, Jin G et al (2010) A 5′-flanking region polymorphism in toll-like receptor 4 is associated with gastric cancer in a Chinese population. J Biomed Res 24:100–106CrossRefPubMedPubMedCentral
35.
go back to reference Cheng I, Plummer SJ, Casey G et al (2007) Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomark Prev 16:352–355CrossRef Cheng I, Plummer SJ, Casey G et al (2007) Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomark Prev 16:352–355CrossRef
36.
go back to reference Yu H, Lin M, Wang X et al (2016) Toll-like receptor 4 polymorphism is associated with increased susceptibility to chronic obstructive pulmonary disease in Han Chinese patients with chronic periodontitis. J Oral Sci 58:555–560CrossRefPubMed Yu H, Lin M, Wang X et al (2016) Toll-like receptor 4 polymorphism is associated with increased susceptibility to chronic obstructive pulmonary disease in Han Chinese patients with chronic periodontitis. J Oral Sci 58:555–560CrossRefPubMed
37.
go back to reference Chantratita N, Tandhavanant S, Seal S et al (2017) TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis. Clin Microbiol Infect 23:47-e1CrossRef Chantratita N, Tandhavanant S, Seal S et al (2017) TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis. Clin Microbiol Infect 23:47-e1CrossRef
38.
go back to reference Zhang L, Xu AG, Zhao W et al (2015) A toll-like receptor 4 (TLR4) variant is associated with asthma severity. Int J Clin Exp Med 8:7849–7854PubMedPubMedCentral Zhang L, Xu AG, Zhao W et al (2015) A toll-like receptor 4 (TLR4) variant is associated with asthma severity. Int J Clin Exp Med 8:7849–7854PubMedPubMedCentral
39.
go back to reference Amoli MM, Thomson W, Hajeer AH et al (2002) Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch–Schönlein purpura. J Rheumatol 29:1404–1407PubMed Amoli MM, Thomson W, Hajeer AH et al (2002) Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch–Schönlein purpura. J Rheumatol 29:1404–1407PubMed
40.
go back to reference Tabel Y, Mir S, Berdeli A (2012) Interleukin 8 gene 2767 A/G polymorphism is associated with increased risk of nephritis in children with Henoch–Schönlein purpura. Rheumatol Int 32:941–947CrossRefPubMed Tabel Y, Mir S, Berdeli A (2012) Interleukin 8 gene 2767 A/G polymorphism is associated with increased risk of nephritis in children with Henoch–Schönlein purpura. Rheumatol Int 32:941–947CrossRefPubMed
41.
go back to reference Amoli MM, Mattey DL, Calviño MC et al (2001) Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch–Schönlein purpura. J Rheumatol 28:1014–1018PubMed Amoli MM, Mattey DL, Calviño MC et al (2001) Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch–Schönlein purpura. J Rheumatol 28:1014–1018PubMed
42.
go back to reference López-Mejías R, Genre F, Remuzgo-Martínez S et al (2016) Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch–Schönlein purpura. Clin Exp Rheumatol 34:S84–S88PubMed López-Mejías R, Genre F, Remuzgo-Martínez S et al (2016) Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch–Schönlein purpura. Clin Exp Rheumatol 34:S84–S88PubMed
43.
go back to reference Aggarwal R, Gupta A, Naru J et al (2016) HLA-DRB1 in Henoch–Schönlein purpura: a susceptibility study from North India. Hum Immunol 77:555–558CrossRefPubMed Aggarwal R, Gupta A, Naru J et al (2016) HLA-DRB1 in Henoch–Schönlein purpura: a susceptibility study from North India. Hum Immunol 77:555–558CrossRefPubMed
44.
go back to reference Soylemezoglu O, Peru H, Gonen S et al (2008) CTLA-4 +49 A/G genotype and HLA-DRB1 polymorphisms in Turkish patients with Henoch–Schonlein purpura. Pediatr Nephrol 23:1239–1244CrossRefPubMed Soylemezoglu O, Peru H, Gonen S et al (2008) CTLA-4 +49 A/G genotype and HLA-DRB1 polymorphisms in Turkish patients with Henoch–Schonlein purpura. Pediatr Nephrol 23:1239–1244CrossRefPubMed
45.
go back to reference Soylemezoglu O, Peru H, Gonen S et al (2008) HLA-DRB1 alleles and Henoch–Schonlein purpura: susceptibility and severity of disease. J Rheumatol 35:1165–1168PubMed Soylemezoglu O, Peru H, Gonen S et al (2008) HLA-DRB1 alleles and Henoch–Schonlein purpura: susceptibility and severity of disease. J Rheumatol 35:1165–1168PubMed
46.
go back to reference Amoli MM, Thomson W, Hajeer AH et al (2001) HLA-DRB1*01 association with Henoch–Schönlein purpura in patients from northwest Spain. J Rheumatol 28:1266–1270PubMed Amoli MM, Thomson W, Hajeer AH et al (2001) HLA-DRB1*01 association with Henoch–Schönlein purpura in patients from northwest Spain. J Rheumatol 28:1266–1270PubMed
47.
go back to reference He X, Yu C, Zhao P et al (2013) The genetics of Henoch–Schönlein purpura: a systematic review and meta-analysis. Rheumatol Int 33:1387–1395CrossRefPubMed He X, Yu C, Zhao P et al (2013) The genetics of Henoch–Schönlein purpura: a systematic review and meta-analysis. Rheumatol Int 33:1387–1395CrossRefPubMed
Metadata
Title
Association of TLR4 gene polymorphisms with childhood Henoch–Schönlein purpura in a Chinese population
Authors
Hui Xu
Guizhen Jiang
Hongqiang Shen
Wei Li
Jianhua Mao
Yanxiang Pan
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3815-1

Other articles of this Issue 11/2017

Rheumatology International 11/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.